Xie, Tongji
Fan, Guangyu
Tang, Le
Xing, Puyuan
Shi, Yuankai
Article History
Received: 26 September 2024
Accepted: 5 November 2024
First Online: 21 December 2024
Declarations
:
: The authors declare no competing interests.
: All authors agreed to submit for consideration for publication in this journal.
: The ORIENT-3 study was approved by the Ethics Committee of each study center. Written informed consent was obtained from all patients of the ORIENT-3 study. The designation of the cohort 3 was approved by the institutional review board of the Cancer Hospital, CAMS (No.23/262-4004). The study was performed in full accordance with the guidelines for Good Clinical Practice and the Declaration of Helsinki.